BG103947A - Derivatives of 9-oxymerythromycin - Google Patents
Derivatives of 9-oxymerythromycinInfo
- Publication number
- BG103947A BG103947A BG103947A BG10394799A BG103947A BG 103947 A BG103947 A BG 103947A BG 103947 A BG103947 A BG 103947A BG 10394799 A BG10394799 A BG 10394799A BG 103947 A BG103947 A BG 103947A
- Authority
- BG
- Bulgaria
- Prior art keywords
- oxymerythromycin
- derivatives
- compounds
- methods
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Abstract
The invention relates to compounds or their pharmaceutically acceptable salts with the formula where R1, R2, R6 and X have the meanings listed in the description. The invention also relates to pharmaceutical compositions containing the compounds, to methods for their application for the treatment of bacterial protozoal infections, as well as to methods for their preparation. 14 claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4934997P | 1997-06-11 | 1997-06-11 | |
PCT/IB1998/000741 WO1998056800A1 (en) | 1997-06-11 | 1998-05-15 | 9-oxime erythromycin derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BG103947A true BG103947A (en) | 2000-07-31 |
Family
ID=21959341
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG103947A BG103947A (en) | 1997-06-11 | 1999-12-03 | Derivatives of 9-oxymerythromycin |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP0988308A1 (en) |
JP (1) | JP2000513026A (en) |
KR (1) | KR20010013660A (en) |
CN (1) | CN1259135A (en) |
AP (1) | AP9801253A0 (en) |
AR (1) | AR012244A1 (en) |
AU (1) | AU7226798A (en) |
BG (1) | BG103947A (en) |
BR (1) | BR9810021A (en) |
CA (1) | CA2293335A1 (en) |
CO (1) | CO4940506A1 (en) |
CZ (1) | CZ9904388A3 (en) |
EA (1) | EA199901016A1 (en) |
GT (1) | GT199800074A (en) |
HN (1) | HN1998000073A (en) |
HR (1) | HRP980316A2 (en) |
HU (1) | HUP0002252A3 (en) |
ID (1) | ID24529A (en) |
IL (1) | IL132767A0 (en) |
IS (1) | IS5251A (en) |
MA (1) | MA26505A1 (en) |
NO (1) | NO996108L (en) |
OA (1) | OA11225A (en) |
PA (1) | PA8451801A1 (en) |
PE (1) | PE79899A1 (en) |
PL (1) | PL337606A1 (en) |
TN (1) | TNSN98083A1 (en) |
TR (1) | TR199902995T2 (en) |
TW (1) | TW448174B (en) |
WO (1) | WO1998056800A1 (en) |
ZA (1) | ZA985018B (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HN1998000159A (en) * | 1997-10-29 | 1999-02-09 | Monsanto Co | DERIVATIVES OF 9- AMINO - 3 CETO ERITROMICINA |
AU5299499A (en) * | 1998-09-22 | 2000-04-10 | Pfizer Products Inc. | Carbamate and carbazate ketolide antibiotics |
FR2786188B1 (en) * | 1998-11-24 | 2002-10-31 | Hoechst Marion Roussel Inc | NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS |
US6258785B1 (en) | 1998-12-02 | 2001-07-10 | Pfizer Inc. | Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin |
EP1298138B1 (en) * | 1998-12-10 | 2006-11-02 | Pfizer Products Inc. | Carbamate and Carbazate Ketolide Antibiotics |
US6284732B1 (en) * | 1998-12-18 | 2001-09-04 | Bio-Rad Laboratories, Inc. | Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases |
ES2272273T3 (en) * | 1999-04-16 | 2007-05-01 | Kosan Biosciences, Inc. | MACROLID ANTI-INFECTIVE AGENTS. |
AP2001002302A0 (en) | 1999-05-24 | 2001-10-25 | Pfizer Prod Inc | 13-Methyl erythromycin derivatives. |
WO2000075156A1 (en) * | 1999-06-07 | 2000-12-14 | Abbott Laboratories | 6-o-carbamate ketolide derivatives |
ID27331A (en) * | 1999-09-29 | 2001-03-29 | Pfizer Prod Inc | MAKING ANTIBIOTIC-ANTIBIOTIC KETOLIDA CARBAMATE |
EP1114826A3 (en) * | 1999-12-29 | 2001-10-31 | Pfizer Products Inc. | Novel antibacterial and prokinetic macrolides |
EP1439186A3 (en) * | 1999-12-29 | 2004-11-03 | Pfizer Products Inc. | Intermediates for novel antibacterial and prokinetic macrolides |
US6946446B2 (en) | 2000-02-24 | 2005-09-20 | Abbott Laboratories | Anti-infective agents useful against multidrug-resistant strains of bacteria |
US6403776B1 (en) | 2000-07-05 | 2002-06-11 | Pfizer Inc. | Synthesis of carbamate ketolide antibiotics |
WO2003090761A1 (en) * | 2002-04-25 | 2003-11-06 | Abbott Laboratories | 9-oxime macrolide antibacterials |
TW200420573A (en) | 2002-09-26 | 2004-10-16 | Rib X Pharmaceuticals Inc | Bifunctional heterocyclic compounds and methods of making and using same |
WO2004080391A2 (en) * | 2003-03-10 | 2004-09-23 | Optimer Pharmaceuticals, Inc. | Novel antibacterial agents |
EP1723159B1 (en) | 2004-02-27 | 2019-06-12 | Melinta Therapeutics, Inc. | Macrocyclic compounds and methods of making and using the same |
CN101917850B (en) | 2007-10-25 | 2016-01-13 | 森普拉制药公司 | The preparation method of macrolide antibacterial agents |
WO2010048601A1 (en) | 2008-10-24 | 2010-04-29 | Cempra Pharmaceuticals, Inc. | Biodefenses using triazole-containing macrolides |
US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
WO2011032052A1 (en) | 2009-09-10 | 2011-03-17 | Cempra Pharmaceuticals, Inc. | Methods for treating malaria, tuberculosis and mac diseases |
CN102146085B (en) * | 2010-02-09 | 2014-03-26 | 北京理工大学 | 9-oxime-ether ketolide derivative, and preparation method and medical composite thereof |
KR20180101643A (en) | 2010-03-22 | 2018-09-12 | 셈프라 파마슈티컬스, 인크. | Crystalline forms of a macrolide, and uses therefor |
BR112012029586A2 (en) | 2010-05-20 | 2016-08-02 | Cempra Pharmaceuticals Inc | processes for preparing macrolides and ketolides and intermediates thereof |
JP6042334B2 (en) | 2010-09-10 | 2016-12-14 | センプラ ファーマシューティカルズ,インコーポレイテッド | Hydrogen bond forming fluoroketolides for disease treatment |
RU2658050C2 (en) | 2012-03-27 | 2018-06-19 | Семпра Фармасьютикалз, Инк. | Parenteral formulations for administering macrolide antibiotics |
US9861616B2 (en) | 2013-03-14 | 2018-01-09 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
KR20160020403A (en) | 2013-03-15 | 2016-02-23 | 셈프라 파마슈티컬스, 인크. | Convergent processes for preparing macrolide antibacterial agents |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL99995A (en) * | 1990-11-21 | 1997-11-20 | Roussel Uclaf | Erythromycin derivatives, their preparation and pharmaceutical compositions containing them |
US5527780A (en) * | 1992-11-05 | 1996-06-18 | Roussel Uclaf | Erythromycin derivatives |
FR2718450B1 (en) * | 1994-04-08 | 1997-01-10 | Roussel Uclaf | New erythromycin derivatives, their preparation process and their use as drugs. |
-
1998
- 1998-05-15 CZ CZ19994388A patent/CZ9904388A3/en unknown
- 1998-05-15 PL PL98337606A patent/PL337606A1/en unknown
- 1998-05-15 EA EA199901016A patent/EA199901016A1/en unknown
- 1998-05-15 CA CA002293335A patent/CA2293335A1/en not_active Abandoned
- 1998-05-15 AU AU72267/98A patent/AU7226798A/en not_active Abandoned
- 1998-05-15 HU HU0002252A patent/HUP0002252A3/en unknown
- 1998-05-15 ID IDW991570A patent/ID24529A/en unknown
- 1998-05-15 TR TR1999/02995T patent/TR199902995T2/en unknown
- 1998-05-15 EP EP98919394A patent/EP0988308A1/en not_active Withdrawn
- 1998-05-15 JP JP11501928A patent/JP2000513026A/en active Pending
- 1998-05-15 KR KR1019997011672A patent/KR20010013660A/en not_active Application Discontinuation
- 1998-05-15 CN CN98805848A patent/CN1259135A/en active Pending
- 1998-05-15 WO PCT/IB1998/000741 patent/WO1998056800A1/en not_active Application Discontinuation
- 1998-05-15 BR BR9810021-1A patent/BR9810021A/en not_active IP Right Cessation
- 1998-05-15 IL IL13276798A patent/IL132767A0/en unknown
- 1998-05-19 HN HN1998000073A patent/HN1998000073A/en unknown
- 1998-05-21 PA PA19988451801A patent/PA8451801A1/en unknown
- 1998-06-04 AP APAP/P/1998/001253A patent/AP9801253A0/en unknown
- 1998-06-05 GT GT199800074A patent/GT199800074A/en unknown
- 1998-06-08 PE PE1998000470A patent/PE79899A1/en not_active Application Discontinuation
- 1998-06-08 TW TW087109086A patent/TW448174B/en active
- 1998-06-09 AR ARP980102703A patent/AR012244A1/en unknown
- 1998-06-10 TN TNTNSN98083A patent/TNSN98083A1/en unknown
- 1998-06-10 ZA ZA9805018A patent/ZA985018B/en unknown
- 1998-06-10 MA MA25105A patent/MA26505A1/en unknown
- 1998-06-11 CO CO98033538A patent/CO4940506A1/en unknown
- 1998-06-11 HR HR60/049,349A patent/HRP980316A2/en not_active Application Discontinuation
-
1999
- 1999-11-16 IS IS5251A patent/IS5251A/en unknown
- 1999-12-03 BG BG103947A patent/BG103947A/en unknown
- 1999-12-03 OA OA9900269A patent/OA11225A/en unknown
- 1999-12-10 NO NO996108A patent/NO996108L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CO4940506A1 (en) | 2000-07-24 |
TW448174B (en) | 2001-08-01 |
HN1998000073A (en) | 1999-01-08 |
WO1998056800A1 (en) | 1998-12-17 |
HRP980316A2 (en) | 1999-04-30 |
CZ9904388A3 (en) | 2002-10-16 |
JP2000513026A (en) | 2000-10-03 |
IL132767A0 (en) | 2001-03-19 |
AU7226798A (en) | 1998-12-30 |
HUP0002252A2 (en) | 2000-12-28 |
NO996108L (en) | 2000-02-10 |
EP0988308A1 (en) | 2000-03-29 |
MA26505A1 (en) | 2004-12-20 |
BR9810021A (en) | 2000-09-19 |
HUP0002252A3 (en) | 2002-01-28 |
PL337606A1 (en) | 2000-08-28 |
EA199901016A1 (en) | 2000-06-26 |
TNSN98083A1 (en) | 2005-03-15 |
AR012244A1 (en) | 2000-09-27 |
OA11225A (en) | 2003-07-17 |
ZA985018B (en) | 1999-12-10 |
GT199800074A (en) | 1999-11-27 |
AP9801253A0 (en) | 1999-12-04 |
CA2293335A1 (en) | 1998-12-17 |
KR20010013660A (en) | 2001-02-26 |
PE79899A1 (en) | 1999-08-25 |
NO996108D0 (en) | 1999-12-10 |
ID24529A (en) | 2000-07-20 |
IS5251A (en) | 1999-11-16 |
CN1259135A (en) | 2000-07-05 |
TR199902995T2 (en) | 2000-02-21 |
PA8451801A1 (en) | 2000-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG103947A (en) | Derivatives of 9-oxymerythromycin | |
BG103945A (en) | Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a | |
BG103417A (en) | Condensed pyrimidine bicyclic derivatives | |
AP9801378A0 (en) | 9-amino-3- keto erythromycin derivatives. | |
BG100946A (en) | New amino acid derivatives, method for their preparation and pharmaceutical compositions containing them | |
MY115662A (en) | Novel compounds with analgesic effect | |
BG103969A (en) | C-4"-substituted macrolide derivatives | |
AP9701019A0 (en) | Phenylamino-substituted tricycle derivatives. | |
BG101110A (en) | Substituted pyrimidine compounds and their application | |
PA8486401A1 (en) | CARBAMATO AND CARBAZATO CETOLID ANTIBIOTICS | |
MY122353A (en) | 13-membered azalides and their use as antibiotic agents | |
MY115211A (en) | Novel amino acid derivatives, their preparation and use | |
CA2286511A1 (en) | Novel macrolide derivatives | |
BG100069A (en) | Amidine derivatives containing heterocylic groups, their preparation and application | |
AP2001002191A0 (en) | 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives. | |
AP9801377A0 (en) | Tricyclic erythromycin derivatives. | |
IL110460A0 (en) | Bis-naphthalimides and pharmaceutical compositions containing them | |
MY120550A (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions. | |
TW252979B (en) | ||
AU2566101A (en) | Compounds and methods for the treatment of pain | |
AP9801235A0 (en) | Erythromycin derivatives. | |
YU46302A (en) | Substituted pyrroles | |
AP9901559A0 (en) | Tricyclic 3-keto derivatives of 6-0-methylerythromycin. | |
MY133140A (en) | N-substituted azabicycloheptane derivatives, their preparation and use | |
MXPA99003849A (en) | 9a,11b-dehydro derivatives of 9-oxime-3-keto-6-0-methylerythromycin. |